Evidence map›Paper›PMID 33882816›Full record

ArticleThe journal of headache and pain2021

Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.

Toshihiko Shimizu, Fumihiko Sakai, Hitoshi Miyake, Tomofumi Sone, Mitsuhiro Sato, Satoshi Tanabe, Yasuhiro Azuma, David W Dodick

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of headache and pain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Toshihiko ShimizuDepartment of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. shimizu-toshi@umin.ac.jp.ORCID http://orcid.org/0000-0002-9417-8525
Fumihiko SakaiThe Saitama International Headache Center, 6-11-1 Honmachi-Higashi, Chuo-ku, Saitama, 338-8577, Japan.
Hitoshi MiyakeCorporate Executive Officer VP, Head of Health Promotion Unit at Fujitsu Co. Ltd, 4-1-1 Kamikodanaka , Nakahara-ku, Kawasaki, 211-8588, Japan.
Tomofumi SoneNational Institute of Public Health, 2-3-6 Minami, Wako-shi, Saitama, 351-0197, Japan.
Mitsuhiro SatoFujitsu General Limited, 3-3-17 Suenaga, Takatsu-ku, Kawasaki, 213-8502, Japan.
Satoshi TanabeHealth Promotion Unit at Fujitsu Co. Ltd, 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, 211-8588, Japan.
Yasuhiro AzumaHealth Promotion Unit at Fujitsu Co. Ltd, 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, 211-8588, Japan.
David W DodickMayo Clinic College of Medicine, 13400 E Shea Blvd, Scottsdale, AZ, USA.
Fujitsu (Japan) · JPKeio University Hospital · JPMayo Clinic in Arizona · USNational Institute of Public Health · JPSaitama International Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMigraine is the leading cause of days lost due to disability in the world among people less than 50 years of age. There is a paucity of evidence on the impact of migraine and other headache disorders and the cost and productivity losses in the workplace.

methodsEmployee population survey assessed prevalence, characteristics, and disability of headache disorders at a Japanese information technology company. This study was supported by the World Health Organization Western Pacific Region Office and International Headache Society.

results2458 (1963men, 495 women) out of 2494 responded to the survey that utilized ICHD-3 beta criteria. Among these, 13% (205 male/123 female) had migraine (M), 53% (1093 male/207 female) had tension-type headache (TTH) and 4% (61 male/27 female) had migraine and TTH (M/TTH). The number of days when productivity at work was reduced by half or more because of headache was significantly higher in migraine compared to TTH. The norm-based scoring of SF-12v2 was significantly lower in M/TTH and M than TTH. The economic loss due to absenteeism for migraine was calculated to be $ 238.3US$/year/person for day-off and 90.2US$/year/person for half-day off using migraine disability assessment score (MIDAS). The economic loss due to presenteeism for migraine was calculated to be $ 375.4US$/year/person using MIDAS and 2217US$/year/person using work productivity and activity impairment questionnaire (WPAI). Furthermore, estimated cost of productivity loss associated with presenteeism using WPAI was calculated at 21.3 billion US$/year in Japan as a whole.

conclusionsThis study revealed a high prevalence and disease burden among employees with migraine that is associated with substantial losses in productivity and employer cost. These results support the development and implementation of workplace programs to improve migraine management in the workplace and reduce the burden and costs associated with lost workplace productivity.

Indexed as

Migraine DisordersQuality of LifeAbsenteeismEfficiencyFemaleHumansJapanMaleWorkplaceAbsenteeismDisabilityEconomic lossImpactMigrainePresenteeismPrevalenceStigmaWorkplaceWork productivity

Identifiers

PMID33882816
PMCPMC8061063
OpenAlexW3152501389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.